Candel Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
117 Kendrick Street, Suite 450, Needham, Massachusetts

Insiders trading volume in the past year

Candel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Laura K. Aguilar 10%+ Owner $2.74M May 6, 2022
Paul Peter Tak Chief Executive Officer, Director $2.14M -$267K -11.1% Jul 17, 2024
Francesca Barone Chief Scientific Officer $1.04M -$166K -13.9% Jul 17, 2024
Seshu Tyagarajan Chief Technology Officer $945K -$176K -15.7% Jul 17, 2024
William Garrett Nichols Chief Medical Officer $741K -$129K -14.8% Jul 17, 2024
Charles Schoch Interim Chief Financial Officer $405K -$117K -22.4% Jul 17, 2024
Jason Amello Chief Financial Officer $182K Nov 28, 2023
Udi Meirav Director $43.9K Jul 26, 2021
Smith Alan E Director $29.3K Jul 26, 2021
Nathan Caffo Chief Business Officer $5.4K Jul 29, 2021
John Canepa Chief Financial Officer Feb 28, 2022
Gary J. Nabel Director Jun 26, 2024
Shaan-Chirag C. Gandhi Director Jul 26, 2021
Paul B. Manning Director Jun 26, 2024
Susan B. Stewart Chief Regulatory Officer Apr 11, 2022
Renee Gaeta Director Jun 26, 2024
Edward J. Benz JR Director Jun 26, 2024
Diem Nguyen Director Jun 26, 2024
Joseph C. Papa Director Jun 26, 2024
Christopher Martell Director Jun 26, 2024
Estuardo Aguilar-Cordova Director Jun 28, 2023
Nicoletta Loggia Director Jun 26, 2024

Recent Insider Transactions by Companies or Individuals for Candel Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.